| References |
| 1. |
Argiles, J. M.,
J. Lopez‐Soriano,
M. A. Ortiz,
J. M. Pou, and
F. J. Lopez‐Soriano.
Interleukin‐1 and beta‐cell function: more than one second messenger?
Endocr. Rev.
13:
515–1524,
1992.
|
| 2. |
Arnett, F. C.,
S. M. Edworthy,
D. A. Bloch, et al.
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.
Arthritis Rheum.
31:
315–1524,
1988.
|
| 3. |
Bebo, B. F., Jr.,
A. A. Vandenbark, and
H. Offner.
Male SJL mice do not relapse after induction of EAE with PLP 139–151.
J. Neurosci. Res.
45:
680–689,
1996.
|
| 4. |
Becker, K. G.,
R. M. Simon,
J. E. Bailey‐Wilson,
B. Freidlin,
W. E. Biddison,
H. F. McFarland, and
J. M. Trent.
Clustering of non‐major histocompatibility complex susceptibility candidate loci in human autoimmune diseases.
Proc. Natl. Acad. Sci. U.S.A.
95:
9979–9984,
1998.
|
| 5. |
Berczi, I.,
F. D. Baragar,
I. M. Chalmers,
E. C. Keystone,
E. Nagy, and
R. J. Warrington.
Hormones in self tolerance and autoimmunity: a role in the pathogenesis of rheumatoid arthritis?
Autoimmunity
16:
45–56,
1993.
|
| 6. |
Bettelli, E.,
M. P. Das,
E. D. Howard,
H. L. Weiner,
R. A. Sobel, and
V. K. Kuchroo.
IL‐10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL‐10‐. and IL‐4‐deficient and transgenic mice.
J. Immunol.
161:
3299–3306,
1998.
|
| 7. |
Brennan, P., and
A. Silman.
Why the gender difference in susceptibility to rheumatoid arthritis?
Ann. Rheum. Dis.
54:
694–695,
1995.
|
| 8. |
Butterfield, R. J.,
J. D. Sudweeks,
E. P. Blankenhorn,
R. Korngold,
J. C. Marini,
J. A. Todd,
R. J. Roper, and
C. Teuscher.
New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice.
J. Immunol.
161:
1860–1867,
1998.
|
| 9. |
Cole, B. C., and
M. M. Griffiths.
Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM.
Arthritis Rheum.
36:
994–1002,
1993.
|
| 10. |
Confavreux, C.,
M. Hutchinson,
M. M. Hours,
P. Cortinovis‐Tourniaire, and
T. Moreau.
Rate of pregnancy‐related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.
N. Engl. J. Med.
339:
285–291,
1998.
|
| 11. |
Cua, D. J.,
R. L. Coffman, and
S. A. Stohlman.
Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen‐presenting cell function.
J. Immunol.
157:
2830–2836,
1996.
|
| 12. |
Cutolo, M.,
A. Sulli,
A. Barone,
B. Seriolo, and
S. Accardo.
Macrophages, synovial tissue and rheumatoid arthritis.
Clin. Exp. Rheumatol.
11:
331–339,
1993.
|
| 13. |
Derijk, R., and
F. Berkenbosch.
The immune‐hypothalamo‐pituitary‐adrenal axis and autoimmunity.
Int. J. Neurosci.
59:
91–100,
1991.
|
| 14. |
Dhabhar, F. S., and
B. S. McEwen.
Stress‐induced enhancement of antigen‐specific cell‐mediated immunity.
J. Immunol.
156:
2608–2615,
1996.
|
| 15. |
Durant, S.,
J. Coulaud,
A. Amrani,
A. el Hasnaoui,
M. Dardenne, and
F. Homo‐Delarche.
Effects of various environmental stress paradigms and adrenalectomy on the expression of autoimmune type 1 diabetes in the non‐obese diabetic (NOD) mouse.
J. Autoimmun.
6:
735–751,
1993.
|
| 16. |
Durie, F. H.,
R. A. Fava, and
R. J. Noelle.
Collagen‐induced arthritis as a model of rheumatoid arthritis.
Clin. Immunol. Immunopathol.
73:
11–18,
1994.
|
| 17. |
Ebers, G. C.,
D. E. Bulman,
A. D. Sadovnick, et al.
A population‐based study of multiple sclerosis in twins.
N. Engl. J. Med.
315:
1638–1642,
1986.
|
| 18. |
Ebers, G. C.,
K. Kukay,
D. E. Bulman, et al.
A full genome search in multiple sclerosis.
Nat. Genet.
13:
472–476,
1996.
|
| 19. |
Eisenbarth, G. S.
Mouse or man. Is GAD the cause of type I diabetes?
Diabetes Care
17:
605–607,
1994.
|
| 20. |
Elliott, M. J.,
R. N. Maini,
M. Feldmann, et al.
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
Arthritis Rheum.
36:
1681–1690,
1993.
|
| 21. |
Faustman, D.
Mechanisms of autoimmunity in type I diabetes.
J. Clin. Immunol.
13:
1–7,
1993.
|
| 22. |
Fecho, K.,
K. A. Maslonek,
L. A. Dykstra, and
D. T. Lysle.
Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine.
Brain Behav. Immun.
7:
253–270,
1993.
|
| 23. |
Felten, D. L.,
S. Y. Felten,
S. L. Carlson,
J. A. Olschowka, and
S. Livnat.
Noradrenergic and peptidergic innervation of lymphoid tissue.
J. Immunol.
135:
755s–765s,
1985.
|
| 24. |
Fitzpatrick, F.,
N. Christeff,
S. Durant,
M. Dardenne,
E. A. Nunez, and
F. Homo‐Delarche.
Glucocorticoids in the nonobese diabetic (NOD) mouse: basal serum levels, effect of endocrine manipulation and immobilization stress.
Life Sci.
50:
1063–1069,
1992.
|
| 25. |
Frederic, F.,
C. Oliver,
E. Wollman,
N. Delhaye‐Bouchaud, and
J. Mariani.
IL‐1 and LPS induce a sexually dimorphic response of the hypothalamo‐pituitary‐adrenal axis in several mouse strains.
Eur. Cytokine Netw.
4:
321–329,
1993.
|
| 26. |
Gautam, A. M.,
R. Liblau,
G. Chelvanayagam,
L. Steinman, and
T. Boston.
A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis.
J. Immunol.
161:
60–64,
1998.
|
| 27. |
Gonzalo, J. A.,
A. Gonzalez‐Garcia,
C. Martinez, and
G. Kroemer.
Glucocorticoid‐mediated control of the activation and clonal deletion of peripheral T cells in vivo.
J. Exp. Med.
177:
1239–1246,
1993.
|
| 28. |
Griffin, A. C.,
W. D. Lo,
A. C. Wolny, and
C. C. Whitacre.
Suppression of experimental autoimmune encephalomyelitis by restraint stress: sex differences.
J. Neuroimmunol.
44:
103–116,
1993.
|
| 29. |
Griffin, A. C., and
C. C. Whitacre.
Sex and strain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: implications for rodent models of autoimmune disease.
J. Neuroimmunol.
35:
53–64,
1991.
|
| 30. |
Haines, J. L.,
M. Ter‐Minassian,
A. Bazyk, et al.
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group.
Nat. Genet.
13:
469–471,
1996.
|
| 31. |
Hanafusa, T.,
J. Miyagawa,
H. Nakajima,
K. Tomita,
M. Kuwajima,
Y. Matsuzawa, and
S. Tarui.
The NOD mouse.
Diabetes Res. Clin. Pract.
24:
S307–S311,
1994.
|
| 32. |
Harris, T. J.,
T. J. Waltman,
S. M. Carter, and
A. S. Maisel.
Effect of prolonged catecholamine infusion on immunoregulatory function: implications in congestive heart failure.
J. Am. Coll. Cardiol.
26:
102–109,
1995.
|
| 33. |
Holden, R. J.
The estrogen connection: the etiological relationship between diabetes, cancer, rheumatoid arthritis and psychiatric disorders.
Med. Hypotheses
45:
169–189,
1995.
|
| 34. |
Homo‐Delarche, F.,
F. Fitzpatrick,
N. Christeff,
E. A. Nunez,
J. F. Bach, and
M. Dardenne.
Sex steroids, glucocorticoids, stress and autoimmunity.
J. Steroid Biochem. Mol. Biol.
40:
619–637,
1991.
|
| 35. |
Janeway, C. A., Jr., and
K. Bottomly.
Signals and signs for lymphocyte responses.
Cell
76:
275–285,
1994.
|
| 36. |
Kikutani, H., and
S. Makino.
The murine autoimmune diabetes model: NOD and related strains.
Adv. Immunol.
51:
285–322,
1992.
|
| 37. |
Kuokkanen, S.,
M. Sundvall,
J. D. Terwilliger,
P. J. Tienari,
J. Wikstrom,
R. Holmdahl,
U. Pettersson, and
L. Peltonen.
A putative vulnerability locus to multiple sclerosis maps to 5p14‐p12 in a region syntenic to the murine locus Eae2.
Nat. Genet.
13:
477–480,
1996.
|
| 38. |
Kurtzke, J. F.,
G. W. Beebe, and
J. E. Norman, Jr.
Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS.
Neurology
35:
672–678,
1985.
|
| 39. |
Lanchbury, J. S., and
M. A. Hall.
T. cell receptor usage in rheumatoid arthritis.
Br. Med. Bull.
51:
346–358,
1995.
|
| 40. |
Lanchbury, J. S., and
C. Pitzalis.
Cellular immune mechanisms in rheumatoid arthritis and other inflammatory arthritides.
Curr. Opin. Immunol.
5:
918–924,
1993.
|
| 41. |
Lehmann, P. V.,
E. E. Sercarz,
T. Forsthuber,
C. M. Dayan, and
G. Gammon.
Determinant spreading and the dynamics of the autoimmune T‐cell repertoire.
Immunol. Today
14:
203–208,
1993.
|
| 42. |
Lydyard, P. M., and
J. C. Edwards.
The pathophysiology of rheumatoid arthritis.
Clin. Exp. Rheumatol.
12:
S55–S58,
1994.
|
| 43. |
MacPhee, I. A.,
F. A. Antoni, and
D. W. Mason.
Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids.
J. Exp. Med.
169:
431–445,
1989.
|
| 44. |
Madden, K. S.,
J. A. Moynihan,
G. J. Brenner,
S. Y. Felten,
D. L. Felten, and
S. Livnat.
Sympathetic nervous system modulation of the immune system. III. Alterations in T. and B cell proliferation and differentiation in vitro following chemical sympathectomy.
J. Neuroimmunol.
49:
77–87,
1994.
|
| 45. |
Martin, R., and
H. F. McFarland.
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
Crit. Rev. Clin. Lab. Sci.
32:
121–182,
1995.
|
| 46. |
Masi, A. T.
Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology?
Clin. Exp. Rheumatol.
13:
227–240,
1995.
|
| 47. |
McDaniel, M. L.,
G. Kwon,
J. R. Hill,
C. A. Marshall, and
J. A. Corbett.
Cytokines and nitric oxide in islet inflammation and diabetes.
Proc. Soc. Exp. Biol. Med.
211:
24–32,
1996.
|
| 48. |
Miller‐Blair, D. J.,
N. Tsuchiya,
A. Yamaguchi,
T. P. Kenny, and
D. L. Robbins.
Immunologic mechanisms in common rheumatologic diseases.
Clin. Orthop.
326:
43–54,
1996.
|
| 49. |
Moder, K. G.,
G. H. Nabozny,
H. S. Luthra, and
C. S. David.
Immunogenetics of collagen induced arthritis in mice: a model for human polyarthritis.
Reg. Immunol.
4:
305–313,
1992.
|
| 50. |
Norman, J. E., Jr.,
J. F. Kurtzke, and
G. W. Beebe.
Epidemiology of multiple sclerosis in U.S. veterans: 2. Latitude, climate and the risk of multiple sclerosis.
J. Chronic Dis.
36:
551–559,
1983.
|
| 51. |
Oldstone, M. B.
Molecular mimicry and autoimmune disease.
Cell
50:
819–820,
1987.
|
| 52. |
Ollier, W., and
W. Thomson.
Population genetics of rheumatoid arthritis.
Rheum. Dis. Clin. North Am.
18:
741–759,
1992.
|
| 53. |
Ollier, W. E., and
A. MacGregor.
Genetic epidemiology of rheumatoid disease.
Br. Med. Bull.
51:
267–285,
1995.
|
| 54. |
Olsson, T.
Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon‐gamma.
J. Neuroimmunol.
40:
211–218,
1992.
|
| 55. |
Olsson, T.
Multiple sclerosis: cerebrospinal fluid.
Ann. Neurol.
36:
S100–S102,
1994.
|
| 56. |
Owens, T., and
S. Sriram.
The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis.
Neurol. Clin.
13:
51–73,
1995.
|
| 57. |
Owerbach, D., and
K. H. Gabbay.
The search for IDDM susceptibility genes: the next generation.
Diabetes
45:
544–551,
1996.
|
| 58. |
Palmer, D. G.
The anatomy of the rheumatoid lesion.
Br. Med. Bull.
51:
286–295,
1995.
|
| 59. |
Panayi, G. S.
A defect in the neuroendocrine axis in rheumatoid arthritis: pathogenetic implications.
Clin. Exp. Rheumatol.
11:
S83–S85,
1993.
|
| 60. |
Panayi, G. S.
Hormonal control of rheumatoid inflammation.
Br. Med. Bull.
51:
462–471,
1995.
|
| 61. |
Panitch, H. S., and
C. T. Bever, Jr.
Clinical trials of interferons in multiple sclerosis. What have we learned?
J. Neuroimmunol.
46:
155–164,
1993.
|
| 62. |
Pennline, K. J.,
E. Roque‐Gaffney, and
M. Monahan.
Recombinant human IL‐10 prevents the onset of diabetes in the nonobese diabetic mouse.
Clin. Immunol. Immunopathol.
71:
169–175,
1994.
|
| 63. |
Rabinovitch, A.
Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?
Diabetes
43:
613–621,
1994.
|
| 64. |
Rabinovitch, A.
An update on cytokines in the pathogenesis of insulin‐dependent diabetes mellitus.
Diabetes Metab. Rev.
14:
129–51,
1998.
|
| 65. |
Racke, M. K.,
A. Bonomo,
D. E. Scott,
B. Cannella,
A. Levine,
C. S. Raine,
E. M. Shevach, and
M. Rocken.
Cytokine‐induced immune deviation as a therapy for inflammatory autoimmune disease.
J. Exp. Med.
180:
1961–1966,
1994.
|
| 66. |
Raine, C. S.
Multiple sclerosis: immune system molecule expression in the central nervous system.
J. Neuropathol. Exp. Neurol.
53:
328–337,
1994.
|
| 67. |
Ray, C. G.,
J. P. Palmer,
J. R. Crossley, and
R. H. Williams.
Coxsackie B virus antibody responses in juvenile‐onset diabetes mellitus.
Clin. Endocrinol. (Oxf.)
12:
375–378,
1980.
|
| 68. |
Reder, A. T.,
M. Thapar, and
M. A. Jensen.
A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease.
Neurology
44:
2289–2294,
1994.
|
| 69. |
Sadovnick, A. D., and
G. C. Ebers.
Genetics of multiple sclerosis.
Neurol. Clin.
13:
99–118,
1995.
|
| 70. |
Salmon, M., and
J. S. Gaston.
The role of T‐lymphocytes in rheumatoid arthritis.
Br. Med. Bull.
51:
332–345,
1995.
|
| 71. |
Samoilova, E. B.,
J. L. Horton, and
Y. Chen.
Acceleration of experimental autoimmune encephalomyelitis in interleukin‐10‐deficient mice: roles of interleukin‐10 in disease progression and recovery.
Cell. Immunol.
188–124,
1998.
|
| 72. |
Sawcer, S.,
H. B. Jones,
R. Feakes,
J. Gray,
N. Smaldon,
J. Chataway,
N. Robertson,
D. Clayton,
P. N. Goodfellow, and
A. Compston.
A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22.
Nat. Genet.
13:
464–468,
1996.
|
| 73. |
Schuurs, A. H., and
H. A. Verheul.
Effects of gender and sex steroids on the immune response.
J. Steroid Biochem.
35:
157–172,
1990.
|
| 74. |
Schwartz, R. H.
A cell culture model for T lymphocyte clonal anergy.
Science
248:
1349–1356,
1990.
|
| 75. |
Serreze, D. V., and
E. H. Leiter.
Genetic and pathogenic basis of autoimmune diabetes in NOD mice.
Curr. Opin. Immunol.
6:
900–906,
1994.
|
| 76. |
Sobel, R. A.
The pathology of multiple sclerosis.
Neurol. Clin.
13:
1–21,
1995.
|
| 77. |
Steinman, L.
Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.
Cell
85:
299–302,
1996.
|
| 78. |
Sternberg, E. M.,
G. P. Chrousos,
R. L. Wilder, and
P. W. Gold.
The stress response and the regulation of inflammatory disease.
Ann. Intern. Med.
117:
854–866,
1992.
|
| 79. |
Sternberg, E. M.,
J. M. Hill,
G. P. Chrousos,
T. Kamilaris,
S. J. Listwak,
P. W. Gold, and
R. L. Wilder.
Inflammatory mediator‐induced hypothalamic‐pituitary‐adrenal axis activation is defective in streptococcal cell wall arthritis‐susceptible Lewis rats.
Proc. Nat. Acad. Sci. U.S.A.
86:
2374–2378,
1989.
|
| 80. |
Sundvall, M.,
J. Jirholt,
H. T. Yang,
L. Jansson,
A. Engstrom,
U. Pettersson, and
R. Holmdahl.
Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis.
Nat. Genet.
10:
313–317,
1995.
|
| 81. |
Symmons, D. P.
What is rheumatoid arthritis?
Bri. Med. Bull.
51:
243–248,
1995.
|
| 82. |
Theofilopoulos, A. N.
The basis of autoimmunity: Part I. Mechanisms of aberrant self‐recognition.
Immunol. Today.
16:
90–98,
1995.
|
| 83. |
Theofilopoulos, A. N.
The basis of autoimmunity: Part II. Genetic predisposition.
Immunol. Today
16:
150–159,
1995.
|
| 84. |
Trapp, B. D.,
J. Peterson,
R. M. Ransohoff,
R. Rudick,
S. Mork, and
L. Bo.
Axonal transection in the lesions of multiple sclerosis.
N. Engl. J. Med.
338:
278–285,
1998.
|
| 85. |
Voskuhl, R. R.,
H. Pitchekian‐Halabi,
A. MacKenzie‐Graham,
H. F. McFarland, and
C. S. Raine.
Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis.
Ann. Neurol.
39:
724–733,
1996.
|
| 86. |
Weiner, H. L.,
A. Friedman,
A. Miller,
S. J. Khoury,
A. al‐Sabbagh,
L. Santos,
M. Sayegh,
R. B. Nussenblatt,
D. E. Trentham, and
D. A. Hafler.
Oral tolerance: immunologic mechanisms and treatment of animal and human organ‐specific autoimmune diseases by oral administration of autoantigens.
Annu. Rev. Immunol.
12:
809–837,
1994.
|
| 87. |
Whitacre, C. C.,
I. E. Gienapp,
A. Meyer,
K. L. Cox, and
N. Javed.
Treatment of autoimmune disease by oral tolerance to autoantigens.
Clin. Immunol. Immunopathol.
80:
S31–S39,
1996.
|
| 88. |
Wicker, L. S.,
J. A. Todd, and
L. B. Peterson.
Genetic control of autoimmune diabetes in the NOD mouse.
Annu. Rev. Immunol.
13:
179–200,
1995.
|
| 89. |
Wilder, R. L.
Neuroendocrine‐immune system interactions and autoimmunity.
Annu. Rev. Immunol.
13:
307–338,
1995.
|
| 90. |
Wilder, R. L.,
R. Lafyatis,
D. E. Yocum,
J. P. Case,
G. K. Kumkumian, and
E. F. Remmers.
Mechanisms of bone and cartilage destruction in rheumatoid arthritis: lessons from the streptococcal cell wall arthritis model in LEW/N rats.
Clin. Exp. Rheumatol.
7:
S123–S127,
1989.
|
| 91. |
Williams, K. C.,
E. Ulvestad, and
W. F. Hickey.
Immunology of multiple sclerosis.
Clin. Neurosci.
2:
229–245,
1994.
|
| 92. |
Winter, W. E.,
T. Chihara, and
D. Schatz.
The genetics of autoimmune diabetes. Approaching a solution to the problem.
Am. J. Dis. Children
147:
1282–1290,
1993.
|
| 93. |
Wucherpfennig, K. W., and
D. A. Hafler.
A review of T‐cell receptors in multiple sclerosis: clonal expansion and persistence of human T‐cells specific for an immunodominant myelin basic protein peptide.
Ann. N. Y. Acad. Sci.
756:
241–258,
1995.
|
| 94. |
Wucherpfennig, K. W., and
J. L. Strominger.
Molecular mimicry in T cell‐mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.
Cell
80:
695–705,
1995.
|
| 95. |
Zamvil, S. S., and
L. Steinman.
The T lymphocyte in experimental allergic encephalomyelitis.
Annu. Rev. Immunol.
8:
579–621,
1990.
|
